Jiri Kassa Selected Research

Jiri Kassa Research Topics

Disease

57	Poisoning 09/2022 - 07/2005
4	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 10/2008
1	Amnesia (Dissociative Amnesia) 01/2018
1	Disease Progression 12/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2014
1	Long Term Adverse Effects 05/2009
1	Organophosphate Poisoning 10/2008
1	Neurobehavioral Manifestations 10/2008
1	Heart Failure 09/2008

Drug/Important Bio-Agent (IBA)

48	OximesIBA 09/2022 - 07/2005
28	tabunIBA 09/2022 - 12/2006
20	asoxime chloride (H16)IBA 01/2018 - 07/2005
15	Atropine FDA LinkGeneric 10/2020 - 01/2007
14	Nerve AgentsIBA 04/2022 - 12/2006
13	SomanIBA 10/2021 - 09/2006
11	Obidoxime Chloride (Obidoxime)IBA 01/2018 - 01/2007
10	SarinIBA 11/2020 - 07/2005
10	Trimedoxime (Trimedoxime Bromide)IBA 07/2017 - 09/2007
9	cyclohexyl methylphosphonofluoridate (cyclosarin)IBA 11/2020 - 09/2006
7	AcetylcholinesteraseIBA 03/2015 - 01/2007
4	Cholinesterase Inhibitors (Anticholinesterases)IBA 10/2021 - 12/2015
3	Tacrine (Cognex)FDA Link 01/2016 - 10/2008
3	VX (EDIM)IBA 08/2013 - 09/2006
2	Biological ProductsIBA 04/2022 - 11/2015
2	MB442IBA 04/2018 - 01/2018
2	MB444IBA 04/2018 - 01/2018
2	MB408IBA 04/2018 - 01/2018
2	1- (4- carbamoylpyridinium)- 4- (3- fluoro- 4- hydroxyiminomethylpyridinium)- but- 2- eneIBA 11/2010 - 08/2010
2	p38 Mitogen-Activated Protein KinasesIBA 05/2009 - 01/2007
2	Transcription Factors (Transcription Factor)IBA 05/2009 - 01/2007
2	Neuroprotective AgentsIBA 01/2009 - 01/2007
2	Cholinergic Antagonists (Anticholinergics)IBA 10/2008 - 12/2006
2	Pharmaceutical PreparationsIBA 10/2008 - 12/2006
1	Memantine (Namenda)FDA Link 10/2021
1	Paraoxon (E600)IBA 10/2020
1	OrganophosphatesIBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Quinuclidinyl BenzilateIBA 01/2018
1	6-chlorotacrineIBA 01/2018
1	MB327IBA 06/2016
1	PropaneIBA 06/2016
1	Cholinesterases (Cholinesterase)IBA 01/2016
1	6- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA 11/2015
1	Cholinergic ReceptorsIBA 06/2014
1	1- (4- carbamoylpyridinium)- 3- (4- hydroxyiminomethylpyridinium)- 2- oxapropaneIBA 03/2011
1	7- methoxy- 1,2,3,4- tetrahydroacridin- 9- amineIBA 10/2008
1	7-methoxytacrine (TA 03)IBA 10/2008
1	Cholinesterase ReactivatorsIBA 10/2008
1	Malathion (Karbofos)FDA LinkGeneric 01/2008
1	Glutathione PeroxidaseIBA 01/2008
1	Cholinergic Agents (Cholinergics)IBA 01/2008
1	Glutathione (Reduced Glutathione)IBA 01/2008
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2008
1	AntidotesIBA 09/2007
1	Mitogen-Activated Protein KinasesIBA 01/2007
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 12/2006
1	BenactyzineIBA 12/2006
1	panpalIBA 12/2006
1	S-(N,N-diethylaminoethyl) isobutyl methylphosphothiolateIBA 09/2006

Therapy/Procedure

2	Therapeutics 10/2020 - 01/2016